LWM
BNGO icon

Laidlaw Wealth Management’s Bionano Genomics BNGO Stock Holding History

Laidlaw Wealth Management’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-17
Closed -$6.1K – 276
2023
Q2 		$6.1K Hold
17
– – ﹤0.01% 351
2023
Q1 		$11.1K Hold
17
– – ﹤0.01% 359
2022
Q4 		$14.6K Buy
+17
New +$21.4K ﹤0.01% 365
2022
Q3 		– Sell
-17
Closed -$14K – 328
2022
Q2 		$14K Hold
17
– – ﹤0.01% 372
2022
Q1 		$26K Sell
17
-106
-86% -$143K ﹤0.01% 392
2021
Q4 		$221K Buy
123
+16
+15% +$42.8K 0.04% 366
2021
Q3 		$352K Buy
107
+53
+98% +$185K 0.09% 176
2021
Q2 		$239K Buy
+54
New +$213K 0.06% 222

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Laidlaw Wealth Management's BNGO Position: Q3 2023 in Review

Laidlaw Wealth Management sold out of Bionano Genomics (BNGO) in Q3 2023, closing a stake of 17 shares — an estimated $6.1K sold.

Laidlaw Wealth Management first reported a position in BNGO in Q2 2021 and held it in 8 quarters. The position peaked at $352K in Q3 2021. 46 funds tracked by Wall St. Rank hold BNGO as of Q3 2023.

  • Laidlaw Wealth Management reported no remaining Bionano Genomics position as of Q3 2023 after selling out during the quarter.
  • Laidlaw Wealth Management sold 17 Bionano Genomics shares in Q3 2023, an estimated $6.1K.
  • Laidlaw Wealth Management first reported a position in Bionano Genomics in Q2 2021 and held it in 8 quarters.
  • Laidlaw Wealth Management's Bionano Genomics position peaked at $352K in Q3 2021.
  • 46 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2023.

Based on Laidlaw Wealth Management's 13F filing for Q3 2023, filed 13 Nov 2023.